leisure time -WSS

leisure time

author：leisure time 2025-09-06 04:14:05 - browse：58929

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： U.S. death rates show how politics are affecting public health

explore

WSS

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

The world needs the new pandemic treaty

New research sheds light on how often breast cancer is overdiagnosed

Why some fertility treatments produce more boy babies

TB outbreak tied to bone grafts underscores testing shortcomings

Hospitals need to get ahead of regulations on climate change

hotspot

leisure time

Wikipedia

Activists slam private health insurers over coverage restrictions

Why we need mandatory labeling of GMO products

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Timeline: Special counsel's investigation into Trump's handling of classified documents

Alkermes shareholders re

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Medicare details structure of new drug price negotiation program

An innovative path out of biotech’s “valley of death”

Dobbs anniversary: the lost opportunity of abortion as health care

Bird flu makes raw milk dangerous to consume, mouse study finds

hotspot

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

After John Oliver segment, STAT readers share their opioid

Who are the detained American citizens released from prison in Iran?

Some medical students still think black patients feel less pain

Pharma budget tightening trickles down to Doximity

Wikipedia

knowledge

explore

hotspot